Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « AffRegInc.i » - entrée « Bari »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Barcelona < Bari < Bari  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000104 (2020) Piero Ruscitti [Italie] ; Paola Cipriani [Italie] ; Vasiliki Liakouli [Italie] ; Daniela Iacono [Italie] ; Ilenia Pantano [Italie] ; Francesco Caso [Italie] ; Federico Perosa [Italie] ; Fabiola Atzeni [Italie] ; Francesco Paolo Cantatore [Italie] ; Raffaele Scarpa [Italie] ; Francesco Ciccia [Italie] ; Roberto Giacomelli [Italie]Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
000150 (2020) Rosanna Dammacco [Italie] ; Giovanni Alessio [Italie] ; Ermete Giancipoli [Italie] ; Patrizia Leone [Italie] ; Anna Cirulli [Italie] ; Leonardo Resta [Italie] ; Angelo Vacca [Italie] ; Franco Dammacco [Italie]Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements.
000200 (2020) Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Florenzo Iannone [Italie] ; Eirik K. Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Dan C. Nordström [Finlande] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Ziga Rotar [Slovénie] ; Maria J. Santos [Portugal] ; Catalin Codreanu [Roumanie] ; Galina Lukina [Russie] ; Sara L. Gale [États-Unis] ; Markus John [Suisse] ; Yves Luder [Suisse] ; Delphine S. Courvoisier [Suisse] ; Cem Gabay [Suisse]Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis.
000505 (2019) Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Deshire Alpizar-Rodriguez [Suisse] ; Catalin Codreanu [Italie] ; Florenzo Iannone [Italie] ; Eirik K. Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Maria J. Santos ; Cem Gabay [Suisse] ; Axel Finckh [Suisse] ; Delphine S. Courvoisier [Suisse]Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution.
000726 (2018) F. Iannone [Italie] ; G. Ferraccioli [Italie] ; L. Sinigaglia [Italie] ; E G Favalli [Italie] ; P. Sarzi-Puttini [Italie] ; F. Atzeni [Italie] ; R. Gorla [Italie] ; C. Bazzani [Italie] ; M. Govoni [Italie] ; I. Farina [Italie] ; E. Gremese [Italie] ; A. Carletto [Italie] ; A. Giollo [Italie] ; M. Galeazzi [Italie] ; R. Foti [Italie] ; L. Bianchino [Italie] ; L. La Grasta [Italie] ; G. Lapadula [Italie]Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
000883 (2018) Kim Lauper [Suisse] ; Dan C. Nordström [Finlande] ; Karel Pavelka [République tchèque] ; Maria Victoria Hernández [Espagne] ; Tore K. Kvien [Norvège] ; Eirik Klami Kristianslund [Norvège] ; Maria Jose Santos [Portugal] ; Žiga Rotar [Slovénie] ; Florenzo Iannone [Italie] ; Catalin Codreanu [Roumanie] ; Galina Lukina [Russie] ; Sara L. Gale [États-Unis] ; Khaled Sarsour [États-Unis] ; Yves Luder [Suisse] ; Delphine Sophie Courvoisier [Suisse] ; Cem Gabay [Suisse]Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration.
000884 (2018) Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Florenzo Iannone [Italie] ; Eirik Klami Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Dan Nordström [Finlande] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Ziga Rotar [Slovénie] ; Maria Jose Santos [Portugal] ; Catalin Codreanu [Roumanie] ; Galina Lukina [Russie] ; Delphine S. Courvoisier [Suisse] ; Cem Gabay [Suisse]Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries.
000A73 (2017) Louise K. Mercer [Royaume-Uni] ; Johan Askling [Suède] ; Pauline Raaschou [Suède] ; William G. Dixon [Royaume-Uni] ; Lene Dreyer [Danemark] ; Merete Lund Hetland [Danemark] ; Anja Strangfeld [Allemagne] ; Angela Zink [Allemagne] ; Xavier Mariette [France] ; Axel Finckh [Suisse] ; Helena Canhao [Portugal] ; Florenzo Iannone [Italie] ; Jakub Zavada [République tchèque] ; Jacques Morel [France] ; Jacques-Eric Gottenberg [France] ; Kimme L. Hyrich [Royaume-Uni] ; Joachim Listing [Allemagne]Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers.
000B43 (2017) Giuseppe Lopalco [Italie] ; Claudia Fabiani [Italie] ; Jurgen Sota [Italie] ; Orso Maria Lucherini [Italie] ; Gian Marco Tosi [Italie] ; Bruno Frediani [Italie] ; Florenzo Iannone [Italie] ; Mauro Galeazzi [Italie] ; Rossella Franceschini [Italie] ; Donato Rigante [Italie] ; Luca Cantarini [Italie]IL-6 blockade in the management of non-infectious uveitis.
000E30 (2016) Florenzo Iannone [Italie] ; Giuseppe Lopalco [Italie] ; Donato Rigante [Italie] ; Ida Orlando [Italie] ; Luca Cantarini [Italie] ; Giovanni Lapadula [Italie]Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy.
000E63 (2016) Florenzo Iannone [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; Mauro Galeazzi [Italie] ; Giovanni Lapadula [Italie]Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritis.
000F05 (2016) P. Portincasa [Italie]Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare.
001D14 (????) Liliana Dinoia [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; Loreto Gesualdo [Italie] ; Michele Rossini [Italie] ; Florenzo Iannone [Italie]Long-term tocilizumab efficacy in a patient with psoriatic arthritis and AA amyloidosis.
001D27 (????) Florenzo Iannone [Italie] ; Marilina Tampoia [Italie] ; Margherita Giannini [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; C Danilo Villalta [Italie] ; Mauro Galeazzi [Italie] ; Giovanni Lapadula [Italie]Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i -k "Bari" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/AffRegInc.i  \
                -Sk "Bari" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Bari
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021